Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
- PMID: 28420743
- PMCID: PMC5430235
- DOI: 10.15252/embj.201696151
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Abstract
Biochemistry textbooks and cell culture experiments seem to be telling us two different things about the significance of external glutamine supply for mammalian cell growth and proliferation. Despite the fact that glutamine is a nonessential amino acid that can be synthesized by cells from glucose-derived carbons and amino acid-derived ammonia, most mammalian cells in tissue culture cannot proliferate or even survive in an environment that does not contain millimolar levels of glutamine. Not only are the levels of glutamine in standard tissue culture media at least ten-fold higher than other amino acids, but glutamine is also the most abundant amino acid in the human bloodstream, where it is assiduously maintained at approximately 0.5 mM through a combination of dietary uptake, de novo synthesis, and muscle protein catabolism. The complex metabolic logic of the proliferating cancer cells' appetite for glutamine-which goes far beyond satisfying their protein synthesis requirements-has only recently come into focus. In this review, we examine the diversity of biosynthetic and regulatory uses of glutamine and their role in proliferation, stress resistance, and cellular identity, as well as discuss the mechanisms that cells utilize in order to adapt to glutamine limitation.
Keywords: cancer; glutamine metabolism; proliferation; stress response.
© 2017 The Authors.
Figures





Similar articles
-
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.Biotechnol Prog. 2005 Jan-Feb;21(1):58-69. doi: 10.1021/bp049827d. Biotechnol Prog. 2005. PMID: 15903241
-
Human 293 cell metabolism in low glutamine-supplied culture: interpretation of metabolic changes through metabolic flux analysis.Metab Eng. 2000 Oct;2(4):277-92. doi: 10.1006/mben.2000.0152. Metab Eng. 2000. PMID: 11120640
-
Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells.Trends Endocrinol Metab. 2019 Jun;30(6):357-368. doi: 10.1016/j.tem.2019.03.003. Epub 2019 Apr 27. Trends Endocrinol Metab. 2019. PMID: 31040047 Review.
-
Glutamine Metabolism in Cancer.Adv Exp Med Biol. 2018;1063:13-32. doi: 10.1007/978-3-319-77736-8_2. Adv Exp Med Biol. 2018. PMID: 29946773 Review.
-
Glutaminolysis: A Hallmark of Cancer Metabolism.Annu Rev Biomed Eng. 2017 Jun 21;19:163-194. doi: 10.1146/annurev-bioeng-071516-044546. Epub 2017 Mar 8. Annu Rev Biomed Eng. 2017. PMID: 28301735 Review.
Cited by
-
Investigating the role of GLUL as a survival factor in cellular adaptation to glutamine depletion via targeted stable isotope resolved metabolomics.Front Mol Biosci. 2022 Aug 12;9:859787. doi: 10.3389/fmolb.2022.859787. eCollection 2022. Front Mol Biosci. 2022. PMID: 36032676 Free PMC article.
-
1-C Metabolism-Serine, Glycine, Folates-In Acute Myeloid Leukemia.Pharmaceuticals (Basel). 2021 Feb 26;14(3):190. doi: 10.3390/ph14030190. Pharmaceuticals (Basel). 2021. PMID: 33652666 Free PMC article. Review.
-
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.Cancer Res. 2020 Nov 1;80(21):4815-4827. doi: 10.1158/0008-5472.CAN-20-0600. Epub 2020 Sep 9. Cancer Res. 2020. PMID: 32907836 Free PMC article. Clinical Trial.
-
TFAP2A Activates S100A2 to Mediate Glutamine Metabolism and Promote Lung Adenocarcinoma Metastasis.Clin Respir J. 2024 Aug;18(8):e13825. doi: 10.1111/crj.13825. Clin Respir J. 2024. PMID: 39187936 Free PMC article.
-
Asparagine, a critical limiting metabolite during glutamine starvation.Mol Cell Oncol. 2018 Apr 11;5(3):e1441633. doi: 10.1080/23723556.2018.1441633. eCollection 2018. Mol Cell Oncol. 2018. PMID: 30250896 Free PMC article.
References
-
- Ahluwalia GS, Grem JL, Hao Z, Cooney DA (1990) Metabolism and action of amino acid analog anti‐cancer agents. Pharmacol Ther 46: 243–271 - PubMed
-
- Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116: 597–602 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources